Le Lézard
Classified in: Health, Science and technology
Subject: CCA

Invitation to Presentation of Sectra's Interim Report on December 8


LINKÖPING, Sweden, Nov. 24, 2017 /PRNewswire/ --The international medical imaging IT and cybersecurity company Sectra (STO: SECT B) will publish its six-month report for the period May to October 2017 on December 8, 2017. Sectra invites analysts, investors and the media to attend a teleconference in conjunction with the publication of the report.

Torbjörn Kronander, President and CEO of Sectra, and Mats Franzén, CFO of Sectra, will present the interim report and answer any questions.

Publication of interim report: 8:00 a.m. December 8, 2017

Presentation/teleconference: 10:00 a.m. December 8, 2017

To participate, call one of the following numbers five to ten minutes before the conference begins:

The presentation will be held in English and can also be followed online at www.sectra.se/irwebcast. A recorded version will be available via this link after the conference.

Approximately 15 minutes before the start, a presentation (PDF document) will be available for download at www.sectra.se/irwebcast

Sectra's financial calendar for the 2017/2018 fiscal year 

Further information about Sectra's financial events and interim reports: http://www.sectra.com/investor/calendar/ 

Subscribe for information 

To subscribe to financial reports, invitations, and information from Sectra via e-mail, please fill in your contact information at www.sectra.com/subscribe.

For further information, please contact:

Helena Pettersson
Chief Investor Relations Officer Sectra AB
ph +46-13-23-52-04
e-mail [email protected]

This information was brought to you by Cision http://news.cision.com

http://news.cision.com/sectra/r/invitation-to-presentation-of-sectra-s-interim-report-on-december-8,c2399077


These press releases may also interest you

at 12:30
The American College of Physicians (ACP) today released an update of its 2017 guideline with clinical recommendations for the use of newer pharmacological treatments of adults with Type 2 diabetes. The clinical guideline is based on the best...

at 12:10
Pieris Pharmaceuticals, Inc. today announced that its Board of Directors has approved a 1-for-80 reverse stock split of the Company's common stock, par value $0.001, which will be effective at 5:00 pm Eastern Time on April 22, 2024. The Company's...

at 12:00
Maintaining asthma medication and asthma control leads to safer perinatal outcomes for pregnant women according to new research published in The Journal of Allergy and Clinical Immunology: In Practice (JACI: In Practice), an official journal of the...

at 11:45
Today at ACP's annual meeting, Internal Medicine Meeting 2024, Annals of Internal Medicine presented three breaking scientific research articles during a live scientific plenary session that featured the authors of those articles. The articles were...

at 11:43
- Cochlear Limited , the global leader in implantable hearing...

at 11:35
The Bone Health and Osteoporosis Foundation (BHOF) announced today its call for nominees for the newly created Robert F. Gagel, M.D. Community Leadership Award. The award's intent is to recognize healthcare professionals who are instrumental in...



News published on and distributed by: